Therapeutic Group: Respiratory Presentation NEOCAFEN IV Injection: Each ml injectable solution contains Caffeine Citrate 20 mg equivalent to Anhydrous Caffeine BP 10 mg. Description Caffeine is structurally related to other methylxanthines, theophylline and theobromine. It is a bronchial smooth muscle relaxant, a CNS stimulant, a cardiac muscle stimulant and a diuretic. Although the mechanism of […]
Therapeutic Group: Prolactin Inhibitor Presentation Cabolac Tablet: Each tablet contains Cabergoline BP 0.5 mg. Description Cabolac Tablet contains Cabergoline, a dopamine receptor agonist. Cabergoline is a dopaminergic ergoline derivative with potent and long-lasting prolactin lowering activity. It acts by direct stimulation of the D2-dopamine receptors on pituitary lactotrophs, thus inhibiting prolactin secretion. Indications 1. Cabolac […]
Therapeutic Group: Respiratory Presentation Askorel SR tablet: Each sustained release tablet contains Butamirate Citrate INN 50 mg. Askorel syrup: Each 5 ml syrup contains Butamirate Citrate INN 7.5 mg. Askorel paediatric drops: Each ml drop contains Butamirate Citrate INN 5 mg. Description Butamirate Citrate belongs to the anti-cough medicines of central action. It exerts expectorant, […]
Therapeutic Group: Anesthetic / Critical Care Presentation Spino Injection: A sterile, hyperbaric solution which is clear, colorless and particle-free contains 5 mg/mL Bupivacaine hydrochloride (0.5% w/v) and 80 mg/mL dextrose (8% w/v) solution. Description Bupivacaine is a long acting local anesthetic of the amide type. Bupivacaine spinal 5 mg/ml is a sterile non-glucose containing solution. […]
Therapeutic Group: Cardiovascular Presentation Bumecard 1: Each tablet contains Bumetanide BP 1mg Bumecard 5: Each tablet contains Bumetanide BP 5 mg Bumecard 2 IV/IM Injection: Each 4 ml ampoule contains Bumetanide BP 2 mg. Description Bumetanide is a loop diuretic with a rapid onset and short duration of action. Pharmacological and clinical studies have shown […]
Therapeutic Group: Respiratory Presentation Budemet 100 Convicap: Each capsule contains Budesonide BP 100 µg and Formoterol Fumarate Dihydrate BP 6 µg inhalation powder. Budemet 200 Convicap: Each capsule contains Budesonide BP 200 µg and Formoterol Fumarate Dihydrate BP 6 µg inhalation powder. Budemet 400 Convicap: Each capsule contains Budesonide BP 400 µg and Formoterol Fumarate […]
Therapeutic Group: Gastro Intestinal Disorders Presentation Budicort ER tablet: Each extended release tablet contains budesonide BP 9 mg. Description Budesonide is a synthetic corticosteroid having potent glucocorticoid activity and weak mineralocorticoid activity. It has approximately 200-fold higher affinity for the glucocorticoid receptor than cortisol and 15-fold than prednisolone. Budesonide is effective against inflammatory bowel diseases. […]
Therapeutic Group: Respiratory Presentation Budicort 0.25 Nebuliser Suspension: Each 2 ml ampoule contains Budesonide BP 0.25 mg. Budicort 0.5 Nebuliser Suspension: Each 2 ml ampoule contains Budesonide BP 0.5 mg. Description Budesonide is a synthetic corticosteroid having potent glucocorticoid activity and weak mineralocorticoid activity. It has approximately a 200-fold higher affinity for the glucocorticoid receptor […]
Therapeutic Group: Respiratory Presentation Each bottle contains 120 metered doses of Budesonide BP. Each actuation delivers Budesonide BP 100 mcg. Description Budesonide is a synthetic corticosteroid having potent glucocorticoid activity and weak mineralocorticoid activity. It has approximately a 200-fold higher affinity for the glucocorticoid receptor and a 1000-fold higher topical anti-inflammatory potency than cortisol. Corticosteroids […]
Therapeutic Group: Respiratory Presentation Mucolyt Tablet: Each tablet contains Bromhexine Hydrochloride BP 8 mg. Mucolyt 100 ml Syrup: Each 5 ml syrup contains Bromhexine Hydrochloride BP 4 mg. Mucolyt 200 ml Syrup: Each 5 ml syrup contains Bromhexine Hydrochloride BP 4 mg. Description Mucolyt is a highly effective mucolytic expectorant. Indications Mucolyt is indicated in […]